Baillie Gifford & Co’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-6,761,547
Closed -$240M 204
2017
Q2
$240M Sell
6,761,547
-57,329
-0.8% -$1.94M 0.32% 63
2017
Q1
$209M Buy
+6,818,876
New +$210M 0.3% 66

Other funds holding QGEN

Baillie Gifford & Co's QGEN Position: Q3 2017 in Review

Baillie Gifford & Co sold out of Qiagen (QGEN) in Q3 2017, closing a stake of 6,761,547 shares — an estimated $240M sold.

Baillie Gifford & Co first reported a position in QGEN in Q1 2017 and held it in 2 quarters. The position peaked at $240M in Q2 2017. 215 funds tracked by Wall St. Rank hold QGEN as of Q3 2017.

  • Baillie Gifford & Co reported no remaining Qiagen position as of Q3 2017 after selling out during the quarter.
  • Baillie Gifford & Co sold 6,761,547 Qiagen shares in Q3 2017, an estimated $240M.
  • Baillie Gifford & Co first reported a position in Qiagen in Q1 2017 and held it in 2 quarters.
  • Baillie Gifford & Co's Qiagen position peaked at $240M in Q2 2017.
  • 215 funds tracked by Wall St. Rank held Qiagen as of Q3 2017.

Based on Baillie Gifford & Co's 13F filing for Q3 2017, filed 20 Oct 2017.